Centre for Orthopaedic Translational Research, School of Surgery, University of Western Australia, Crawley, Australia.
Tissue Eng Part B Rev. 2013 Apr;19(2):133-46. doi: 10.1089/ten.TEB.2012.0295. Epub 2012 Nov 19.
Tendon and ligament injury is a worldwide health problem, but the treatment options remain limited. Tendon and ligament engineering might provide an alternative tissue source for the surgical replacement of injured tendon. A bioreactor provides a controllable environment enabling the systematic study of specific biological, biochemical, and biomechanical requirements to design and manufacture engineered tendon/ligament tissue. Furthermore, the tendon/ligament bioreactor system can provide a suitable culture environment, which mimics the dynamics of the in vivo environment for tendon/ligament maturation. For clinical settings, bioreactors also have the advantages of less-contamination risk, high reproducibility of cell propagation by minimizing manual operation, and a consistent end product. In this review, we identify the key components, design preferences, and criteria that are required for the development of an ideal bioreactor for engineering tendons and ligaments.
肌腱和韧带损伤是一个全球性的健康问题,但治疗选择仍然有限。肌腱和韧带工程可能为受伤肌腱的手术替代提供一种替代的组织来源。生物反应器提供了一个可控的环境,使特定的生物学、生物化学和生物力学要求的系统研究能够设计和制造工程化的肌腱/韧带组织。此外,肌腱/韧带生物反应器系统可以提供一个合适的培养环境,模拟体内环境的动力学,促进肌腱/韧带成熟。对于临床环境,生物反应器还具有污染风险低、通过最小化手动操作最大限度地提高细胞繁殖的可重复性以及一致的最终产品等优点。在这篇综述中,我们确定了用于工程化肌腱和韧带的理想生物反应器的关键组件、设计偏好和标准。